SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Teijeiro, R.
Right arrow Articles by Chiale, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teijeiro, R.
Right arrow Articles by Chiale, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Recording of High V1-V3 Precordial Leads May Be Essential to the Diagnosis of Brugada Syndrome During the Ajmaline Test

Rodrigo Teijeiro, MD

Division of Cardiology, Hospital General de Agudos Jose M. Ramos Mejia, Buenos Aires, Argentina

Hugo A. Garro, MD

Division of Cardiology, Hospital General de Agudos Jose M. Ramos Mejia, Buenos Aires, Argentina

Rafael S. Acunzo, MD

Division of Cardiology, Hospital General de Agudos Jose M. Ramos Mejia, Buenos Aires, Argentina

Ernesto Albino, MD

Division of Cardiology, Hospital General de Agudos Jose M. Ramos Mejia, Buenos Aires, Argentina

Pablo A. Chiale, MD

Division of Cardiology, Hospital General de Agudos Jose M. Ramos Mejia, Pontificia Universidad Católica, Buenos Aires, Argentina, pablochiale{at}fibertel.com.ar

Sodium channel-blocking agents are routinely used to unveil the Brugada syndrome in patients in whom the typical electrocardiographic pattern is absent or doubtful. In this article, the authors report a patient with syncopal episodes of unknown origin in whom the conventional electrocardiographic result was normal and a negligibly small "saddle back" type repolarization was present in lead V2 recorded 2 intercostal spaces above the conventional site. Intravenous ajmaline (50 mg) did not elicit the type 1 pattern of the Brugada syndrome in the precordial leads obtained at their usual level, but a clear-cut coved-type repolarization was apparent in high right precordial leads. These findings indicate that high precordial leads should be routinely recorded while assessing the ajmaline test in patients suspected of having the Brugada syndrome

Key Words: Brugada syndrome • precordial electrocardiographic mapping • sodium channel-blocking agents

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 11, No. 2, 153-155 (2006)
DOI: 10.1177/1074248406288760


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement